Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Schiff Nutrition names two new board members
The company has also announced that Glenn Schaeffer resigned from the board to pursue other business opportunities. Accordingly, Schiff’s board will have nine members. Mr Hyatt is a
The company has also announced that Glenn Schaeffer resigned from the board to pursue other business opportunities. Accordingly, Schiff’s board will have nine members. Mr Hyatt is a
According to the company, Kendrick will enable Sanofi-Aventis to reinforce its leadership in Mexico and further extend the range of its pharmaceutical portfolio. This acquisition is claimed to
Osiris Therapeutics, a stem cell therapeutic company, has agreed with NuVasive, a medical device company, to accelerate transfer of the Osteocel business. Under the terms of amendments to
Cytokinetics has announced positive results from a final Phase IIa clinical trial evaluating CK-1827452 in stable heart failure patients. The clinical trial was multi-center, double-blind, randomized and placebo-controlled.
According to Cepheid, the test is designed for the simultaneous detection of nasal carriage of both Methicillin-resistant Staphylococcus aureus (MRSA) and Methicillin-sensitive Staphylococcus aureus in less than one
The FDA is expected to make a decision whether to grant accelerated approval of Avastin for use in this most aggressive form of brain cancer by May 5,
This patent offers protection for the use of NB S101(strontium malonate) for the treatment of osteoporosis and related conditions while confirming that the innovative product, NB S101, demonstrated
As President and CEO, Mr Narachi will see through the completion of the remaining three Phase III trials for Contrave (naltrexone sustained release (SR)/bupropion SR) and its new
Of the $1.27 million contract, $1.13 million is Federal money provided by the NCI, and $146,088 is the contractor’s share provided by Intrinsic Bioprobes. This contract is in
ArunA Biomedical and Open Biosystems will launch the complete and fully validated induced pluripotent stem cell (viPS) kits containing all the tools and reagents necessary to generate patient